Inner Nuclear Macular Microcyst is a Risk Factor for NCT03934190

Updated 06/21/2024

Clinical Trial Details — Status: Completed

Administrative data
NCT number	NCT03934190
Other study ID #	141012
Secondary ID
Status	Completed
Phase
First received
Last updated
Start date	October 1, 2014
Est. completion date	March 31, 2019

Study information
Verified date	April 2019
Source	Changhua Christian Hospital
Contact	n/a
Is FDA regulated	No
Health authority
Study type	Observational

Clinical Trial Summary

To evaluate the visual acuity, macular thickness, morphological changes after cataract surgery in eyes with previous vitrectomy for macular pucker. Associated risk factors were also investigated.

Recruitment information / eligibility
Status	Completed
Enrollment	46
Est. completion date	March 31, 2019
Est. primary completion date	January 31, 2019
Accepts healthy volunteers	No
Gender	All
Age group	50 Years to 80 Years
Eligibility	Inclusion Criteria: - Patients had macular pucker surgery before cataract surgery. - Follow up over 1 year. Exclusion Criteria: - Patients had any surgical complications such as posterior capsule rupture, vitreous loss, prolapse through the wound or iris trauma - Patients had diabetes mellitus. - Patients had uveitis or other inflammatory eye disease. - Patients had history of retinal vein occlusion. - Patients had retinal detachment; or previous vitrectomy for a disease other than macular pucker.

Study Design

Related Conditions & MeSH terms

Locations
Country	Name	City	State
n/a

Sponsors *(1)*
Lead Sponsor	Collaborator
Changhua Christian Hospital

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	Wilcoxon Signed-Rank test	A statistical comparison of average of different time point	1 day, 1 week, 1 month, 3 months, 6 months and 1 year
Secondary	visual acuity	visual acuity change in logMAR in different time point	1 day, 1 week, 1 month, 3 months, 6 months and 1 year

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT01969929` - Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy	N/A
	Completed	`NCT00555269` - Membrane Blue Versus Infracyanine Green	N/A
	Terminated	`NCT04802265` - EpiRetinal Membrane Peeling and Internal Limiting Membrane
	Completed	`NCT04397068` - Compare ELP in Patients With Elective Phaco-VTX Surgery in One Eye and a Single Lens Phaco Surgery on the Other Eye	N/A
	Completed	`NCT02319655` - Morphologic Changes After Membrane Peeling With Air Tamponade and Balanced Salt Solution	N/A
	Completed	`NCT05517473` - Efficacy and Safety Evaluation of MONOBLUE DUAL View and MONOBLUE ILM View Vital Stains
	Completed	`NCT01162356` - Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study	N/A
	Recruiting	`NCT01083004` - Brilliant Blue Versus Indocyanine Green	Phase 3
	Recruiting	`NCT04802915` - Intraoperative Analysis of the Central Retina in ERF	N/A
	Recruiting	`NCT04501367` - Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.	Phase 4
	Recruiting	`NCT05860985` - Zeiss RESIGHT Disposable Lenses Evaluation Study	N/A